D. Kearney

Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.

D. Fitzgerald, D. Byrne, A. Leahy, 2000, Circulation.

Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen.

P Anderson, H. Berman, P. B. Jensen, 2000, The Journal of clinical investigation.

The anti-thrombotic effects of statins.

D. Kearney, D. Fitzgerald, 1999, Journal of the American College of Cardiology.

Diet modification alters plasma HDL cholesterol concentrations but not the transport of HDL cholesteryl esters to the liver in the hamster.

D. Kearney, L. Woollett, D. Spady, 1997, Journal of lipid research.

Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.

D. Fitzgerald, D. Cox, D. Kearney, 2004, Journal of the American College of Cardiology.

Polyunsaturated fatty acids up-regulate hepatic scavenger receptor B1 (SR-BI) expression and HDL cholesteryl ester uptake in the hamster.

H. Hobbs, D. Kearney, D. Spady, 1999, Journal of lipid research.

Molecular cloning and characterization of SCaMPER, a sphingolipid Ca2+ release-mediating protein from endoplasmic reticulum.

J. Almenoff, S. Kim, X. Rudner, 1996, Proceedings of the National Academy of Sciences of the United States of America.

A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma

A. Duatti, M. Giganti, D. Kearney, 2004, Nuclear medicine communications.